NCT00111423View on ClinicalTrials.gov

Evaluating the Safety of Extended Treatment With Pegsunercept (PEG sTNF-RI)in Subjects With Rheumatoid Arthritis (RA)

PHASE2CompletedINTERVENTIONAL
Enrollment

216

Participants

Timeline

Start Date

August 31, 2002

Conditions
Rheumatoid Arthritis
Interventions
DRUG

Pegsunercept (PEG sTNF-RI)

Sponsors

Lead Sponsor

Amgen
All Listed Sponsors
lead

Amgen

INDUSTRY